PH
Therapeutic Areas
TRIO Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TRAILBody™ Program | Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | Pre-clinical |
| TIE-ADC™ Program | Triple Negative Breast Cancer (TNBC) and Non-Small Cell Lung Cancer (NSCLC) | Pre-clinical |